CORE Biogenesis, a pioneering biotechnology company, is proud to announce its strategic entry into the Personal Care & Cosmetics (PC&C) industry with the launch of two groundbreaking biotechnology active ingredients. The newly introduced peauvitaᵀᴹ and peauforiaᵀᴹ, derived from the fusion of the French word for skin, "peau," with terms that evoke vitality and euphoria, represent a significant leap forward in skin care innovation. These advanced Growth Factors offer unprecedented stability and efficacy, poised to transform the skin care landscape.
Leveraging its patent-pending plant biofactory production process, CORE Biogenesis has mastered the art of producing bioactive compounds, such as peptides and proteins, within the seeds of Camelina Sativa plants. These proteins are expertly fused to the surface of Oleosomes—natural oilseed reservoirs—ensuring the stabilization of actives and enhancing their delivery to the skin.
“Our focus has been on Growth Factors, essential proteins naturally found in the skin that diminish with age, contributing to the aging process,” said Alexandre Reeber, President and CEO of CORE Biogenesis. “Through our innovative technology, we’ve successfully stabilized two of the most sought-after Growth Factors, EGF and FGF-2, which promise enhanced efficacy for skin care brands and, ultimately, the consumer.”
peauvitaᵀᴹ (EGF - Oleosome) and peauforiaᵀᴹ (FGF2 - Oleosome) have undergone rigorous placebo-controlled clinical trials involving 60 participants, utilizing only a 1% incorporation rate of each active. The third-party study revealed that peauvitaᵀᴹ significantly reduces the appearance of fine lines and wrinkles while boosting skin firmness in just 14 days. Moreover, peauforiaᵀᴹ was shown to diminish melanin in hyperpigmented areas and restore the skin barrier within the same timeframe. Together, these actives offer a comprehensive solution targeting the four primary signs of aging.
“The clinical results were truly remarkable, with noticeable improvements in just 14 days,” commented Tony Abboud, Head of Cosmetics at CORE Biogenesis. “I am confident that skin care brands worldwide will be eager to incorporate peauvitaᵀᴹ and peauforiaᵀᴹ into their upcoming formulations.”
To support the launch, CORE Biogenesis has established a robust sales network across the United States. For more information, visit www.peauforia.com Additionally, CORE Biogenesis, in collaboration with Covalo, will be hosting a global webinar titled “Beyond Retinol: Unlocking the Next-Generation of Anti-Aging with Growth Factors” featuring Dr. Hannah Sivak and Dr. Hadley King on October 9th, 2024. Reserve your spot here.